V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials.
about
Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinomaThe prognostic value of 18F-FDG PET/CT for hepatocellular carcinoma treated with transarterial chemoembolization (TACE).Validation of a Preclinical Model of Diethylnitrosamine-Induced Hepatic Neoplasia in Yucatan Miniature PigsReassessing hepatocellular carcinoma staging in a changing patient population.Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a.Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinoma.Major challenges limiting liver transplantation in the United States.I-CLIP: improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP score.Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma.Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma.Predictive biomarkers of antiangiogenic therapy for advanced hepatocellular carcinoma: where are we?Serum VEGF level is associated with the outcome of patients with hepatocellular carcinoma: a meta-analysis.Re-evaluating transarterial chemoembolization for the treatment of hepatocellular carcinoma: Consensus recommendations and review by an International Expert Panel.Staging systems of hepatocellular carcinoma: a review of literature.Diagnosis and treatment of hepatocellular carcinoma: An update.Staging systems for hepatocellular carcinoma: Current status and future perspectivesValidation and ranking of seven staging systems of hepatocellular carcinoma.Overview of Staging Systems for Hepatocellular Carcinoma and Implications for Interventional Radiology.Application of the Immunoscore as prognostic tool for hepatocellular carcinoma.Serum levels of angiogenic and anti-angiogenic factors: their prognostic relevance in locally advanced hepatocellular carcinoma.The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: final results of the START trial.Prognostic significance of sodium-potassium ATPase regulator, FXYD3, in human hepatocellular carcinoma.Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.
P2860
Q28247867-4322BED0-2870-4F06-8D0F-E1BC17BB622DQ33686817-BAEF8409-200C-4835-A308-8ED2028D633FQ33688431-7ED122E9-9C3C-4333-8257-29A0976D13FDQ33767286-19478B93-340B-4A9A-8BF6-443228BD7B2EQ34344956-CF35D2BC-303D-4645-A9C8-194FE1B94A2EQ34402650-13F22785-9FE3-47BC-A9D8-6E1BD31FD1EBQ35194675-9BE537CE-EE1A-42AB-9914-0C096E36F9FEQ35208826-900741B6-4EDB-4E02-A4A4-92B6D4E1DE9DQ35289603-293B2F7A-1D64-46A6-B8F7-4A6B261AAF2EQ36625954-9F198E26-0999-4A0C-9E79-D6013546942EQ37088265-28839314-B9C2-4A83-AA6A-F203C299896DQ37584706-5D3E7656-E1C2-4BD9-95C3-D33009443D7FQ38164112-94FFE7E8-9A38-4583-A4CF-83E7D21E42E0Q38207014-2E9DA473-A3EE-46DC-8DF5-8A40E162CF33Q38408866-C6972C36-4364-4A15-AA89-F5AEC133EAD8Q38408876-705022E5-05F1-46A2-958F-B9929FA3D850Q38686026-97DAFCA2-7514-44F9-BFCA-88A82C461CF1Q39349696-E0E5BDF7-79D6-4B4B-968F-BF57218145AAQ42368651-19D989FE-1FB6-4297-8E07-4712BB6D5524Q45339888-21B7AE01-2E1B-40E3-B199-2FEEC4D310C2Q48238287-CD633BC2-BA74-4C13-8E2D-2A99E4A09154Q49533065-DC2BB7E0-249F-4031-A6BC-1688812F8FA9Q50501948-A5CC8AB4-0BF6-4AAA-8ADA-ADBF2399BE96
P2860
V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
V-CLIP: Integrating plasma vas ...... carcinoma for clinical trials.
@ast
V-CLIP: Integrating plasma vas ...... carcinoma for clinical trials.
@en
V-CLIP: Integrating plasma vas ...... carcinoma for clinical trials.
@nl
type
label
V-CLIP: Integrating plasma vas ...... carcinoma for clinical trials.
@ast
V-CLIP: Integrating plasma vas ...... carcinoma for clinical trials.
@en
V-CLIP: Integrating plasma vas ...... carcinoma for clinical trials.
@nl
prefLabel
V-CLIP: Integrating plasma vas ...... carcinoma for clinical trials.
@ast
V-CLIP: Integrating plasma vas ...... carcinoma for clinical trials.
@en
V-CLIP: Integrating plasma vas ...... carcinoma for clinical trials.
@nl
P2093
P2860
P356
P1433
P1476
V-CLIP: Integrating plasma vas ...... carcinoma for clinical trials.
@en
P2093
Ahmed O Kaseb
Asif Rashid
James L Abbruzzese
Jeffrey S Morris
Lianchun Xiao
Manal M Hassan
Priyanka Pathak
Richard Lozano
Vikas Kumar
P2860
P304
P356
10.1002/CNCR.25791
P407
P577
2010-12-14T00:00:00Z